
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Bristol Myers Squibb | Belatacept | Nulojix |  | 2011-06-17 | $26 M | Y2013 |
| Hansa Biopharma | Imlifidase | Idefirix |  | 2020-08-25 |  |  |
| Novartis | Basiliximab | Simulect |  | 1998-10-09 |  |  |
| Pfizer | Sirolimus | Rapamune |  | 2001-03-13 | $170 M | Y2016 |
| Roche | Daclizumab | Zenapax |  | 1999-02-26 |  |  |
| Teva | Tacrolimus | Tacforius |  | 2017-12-08 |  |  |